Plantform is a biopharmaceutical company focused on the rapid development and production of specialty antibody and protein drugs.

Posted: Feb 16, 2023

See more Success Stories


Fulfilling the power of ag-pharma in life-saving medications

University of Guelph spin-off PlantForm Corporation uses the power of plants to combat medical needs for human and animal health. Their revolutionary plant-based vivoXPRESS® platform makes it simpler, quicker, and less expensive to develop approved biologic pharmaceuticals for new markets.

PlantForm uses Nicotiana bentheminia plants to create low-cost biosimilar and/or biobetter plant-based versions of medications on the market. On the innovative side, one of the products the company is developing stems from a project proposed by the Department of National Defence for a drug as an antidote to ricin, a powerful biological warfare agent.

Today, this project is backed by the Canadian, United Kingdom and Australian governments to be marketed internationally within the next few years.

“Our long-term relationship with Bioenterprise has had significant impact on helping us move some projects forward,” says PlantForm CEO Don Stewart.

Plantform also recently entered the animal health sector, with two products in development and another undergoing regulatory approvals.

“Most recently, Bioenterprise proposed that we should apply for a spot to pitch at the 2022 Animal Health Corridor conference in Kansas,” explains Stewart.

Bioenterprise helped with the initial application to speak as well as developing a strong pitch presentation for the event, where the technology was well received and has generated interest among animal health companies.


Not yet following us on social media? Follow Bioenterprise on TwitterLinkedInTikTok, and subscribe to our YouTube channel for industry news, events, and business development opportunities.